Clarivate Life Sciences & Health Rebrands as Insira

New York, NY - Insira^SM , the former Life Sciences & Healthcare business ("LS&H") of Clarivate plc (NYSE: CLVT), today introduced its new name and brand.

"Launching as Insira marks a defining moment for our company and the customers we serve," said Henry Levy, Chief Executive Officer of Insira. "We are combining the depth of our legacy data and the unmatched expertise of our people, with the power of evolving AI to drive improved strategic certainty. Insira exists to convert high-quality intelligence into immediate confidence, making the success of therapeutic and health technologies a predictable reality."

To discover the vision behind Insira and explore Insira's latest capabilities, visit insiraglobal.com.

About Altaris

Altaris is an investment firm with an exclusive focus on acquiring and building companies in the healthcare industry. Since its inception in 2003, Altaris has invested in more than 50 companies across a range of healthcare subsectors, with a consistent goal of delivering value to the healthcare system and generating attractive financial returns for investors. Altaris is headquartered in New York City and manages $10 billion of equity capital. For more information, please visit www.altariscap.com.

About Insira

Insira gives life sciences and healthcare teams the data, insights and expertise to know what's next and decide how to get there. Through connected data with embedded AI in platforms such as Cortellis, DRG and Dialog, Insira delivers data before demand and insights beyond the obvious straight into the flow of work. In a rapidly evolving landscape, Insira supports customers in making informed decisions, helping teams stay ahead of the question and driving the ultimate success of treatment innovations. Learn more at insiraglobal.com.